Clin Med Insights Oncol
Clin Med Insights Oncol
Country: Unknown
Publisher: Unknown
Publication Period: Unknown
215
Papers in Database
Journal Information
Publication Details
Additional Information
Subject Term Count: 1
Last Updated: Aug 05, 2025
Recent Papers
View All 215 PapersCharacterization and Survival Benefit of Drug Approvals for Metastatic Prostate Cancer, 2004 to 2022.
Benjamin DJ, Rezazadeh Kalebasty A.
Copper Chaperone for Superoxide Dismutase Subtypes as a Prognostic Marker in Luminal B Breast Cancer.
Li Y, Du W, Yang R, Wei X, Li H, Zhang X.
Peripheral Blood CD8<sup>+</sup> CD28<sup>+</sup> T Cells as an Independent Predictor of Treatment Response and Surviva…
Wang S, Mu X, Wang X, Chen L, Lu C, Song L.
Prognostic Significance of the Cachexia Index in Patients with Non-Small-Cell Lung Cancer and Brain Metastases after St…
Xu H, Zhang B, Zhang Y, Yang C, Bo C, Guo Y, Cheng Y, He L.
Risk Factors for Distant Metastasis in T3 T4 Rectal Cancer.
Tang C, Xu J, Lin M, Qiu S, Wang H, Zuo X, Liu M, Wang P.
Risk Models for Predicting the Recurrence and Survival in Patients With Hepatocellular Carcinoma Undergoing Radio-Frequ…
Yang J, Cui L, Zhang W, Yin Z, Bao S, Liu L.
The Implication of Growth Arrest-Specific 5 rs145204276 Polymorphism and Serum Expression of Sirtuin 1, Transforming Gr…
Hasona NA, Elsabahy M, Shaker OG, Zaki O, Ayeldeen G.
Anlotinib as Monotherapy or Combination Therapy for Recurrent High-Grade Glioma: A Retrospective Study.
Yin J, Yin W, Zheng L, Li Y, Luo C, Zhang S, Duan L, Zhou H, Cheng K, Lang J, Xu K.
A Phase II Study of <sup>131</sup>I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.
Jang YJ, Lim SM, Lee I, Byun BH, Lim I, Kim BI, Choi CW, Lee SS, Yang SH, Na II, Lee HR, Shin DY, K…
Association Between Polymorphism in Diabetes Susceptibility Gene Insulin-Like Growth Factor 2mRNA-Binding Protein 2 and…
Zhou W, Gao Q, He C, Wang L, Wang Y, Feng L, Li W, Liu W, Ma R, Liu L.